Corticotrophin treatment in multiple sclerosis.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000152:Acne Vulgaris / Q000139:chemically induced; D000208:Acute Disease; D000311:Adrenal Glands / Q000187:drug effects; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D001786:Blood Glucose; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004487:Edema / Q000139:chemically induced; D005260:Female; D006029:Glycosuria / Q000139:chemically induced; D006628:Hirsutism / Q000139:chemically induced; D006801:Humans; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010919:Placebos
D015065:17-Hydroxycorticosteroids; D001786:Blood Glucose; D010919:Placebos; D000324:Adrenocorticotropic Hormone